BioWorld

May 12, 1998

View Archived Issues

Ligand Buys Out Seragen In $67M Deal For CTCL

Read More

Novastan Not Approvable, FDA Tells Texas Biotech

Read More

Other News To Note

Read More

Wyeth-Ayerst Buys Apollon For DNA Vaccines Research

Read More

Phase III Trial Data Mixed For Diatide's Imaging Agent

Read More

Testosterone, Interleukin-6 Wear Black Hats In Tumor Growth

Read More

Monsanto Buys DeKalb, Delta; Transactions Valued At $4B

Read More